The relationship between diabetes and gum disease is a two-way street. Treating periodontal disease in people with diabetes reduces A1c by 0.3 to 0.4%, according to multiple meta-analyses. That reduction is comparable to adding a second diabetes medication. At the same time, diabetes triples the risk of developing severe gum disease, and severe gum disease roughly doubles the risk of developing type 2 diabetes.1
This bidirectional relationship runs through inflammation. Each condition amplifies the inflammatory burden of the other, creating a cycle that worsens both metabolic control and periodontal health.3
Treating gum disease lowers A1c by 0.3 to 0.4%
A 2022 Cochrane systematic review analyzed randomized controlled trials comparing periodontal treatment to no treatment or usual care in people with diabetes. The review found moderate-quality evidence that treating gum disease reduces A1c by 0.3 to 0.4% at three to four months post-treatment.8 That effect size matches what you would expect from adding a second oral diabetes medication.
A 2020 meta-analysis of 12 studies confirmed similar findings. Non-surgical periodontal treatment (scaling and root planing) reduced A1c by an average of 0.36% compared to control groups receiving no treatment or delayed treatment.9
The largest single trial, published in Lancet Diabetes & Endocrinology in 2018, followed 264 people with type 2 diabetes and moderate to severe periodontitis for 12 months. The group receiving intensive periodontal treatment (scaling, root planing, and ongoing maintenance) showed a mean A1c reduction of 0.6% at 12 months compared to the group receiving only basic oral hygiene instruction.10 Participants also showed improvements in inflammatory markers and endothelial function.
A 2017 randomized trial in Japan demonstrated similar results plus additional benefits. People with type 2 diabetes who received non-surgical periodontal treatment showed not only improved A1c but also reduced oxidative stress and better quality-of-life scores compared to those who delayed treatment.14
The A1c reduction from treating gum disease (0.3 to 0.4%) is clinically meaningful. In diabetes care, every 1% reduction in A1c reduces microvascular complications by about 37%. A 0.4% reduction translates to roughly 15% lower risk of complications like retinopathy and nephropathy.
Evidence quality and limitations
The Cochrane review rated the evidence as moderate quality, not high. Most trials had small sample sizes (fewer than 100 participants), short follow-up periods (three to six months), and varied in how well they controlled for confounding factors like changes in diabetes medication or diet.8
The review also noted that most studies did not report adverse events from periodontal treatment, making it difficult to assess the risk-benefit balance comprehensively. That said, serious adverse events from scaling and root planing are rare.
The table below summarizes key trials and their glycemic outcomes.
| Study design | Treatment protocol | A1c reduction | Sample size | Follow-up |
|---|---|---|---|---|
| Meta-analysis (Cochrane) | Any periodontal treatment vs control | 0.3 to 0.4% | Multiple RCTs | 3 to 4 months |
| Meta-analysis | Scaling and root planing vs control | 0.36% | 12 studies, 1,498 participants | 3 to 6 months |
| RCT (Lancet) | Intensive periodontal therapy + maintenance | 0.6% | 264 participants | 12 months |
| RCT (Japan) | Non-surgical periodontal treatment | Significant improvement | 40 participants | 3 months |
Clinical trials showing A1c reduction from periodontal treatment in people with diabetes
How diabetes and gum disease worsen each other
The question of whether diabetes causes gum disease or gum disease affects diabetes has a clear answer from the cohort evidence. Both directions are true.
A 2021 meta-analysis of cohort studies quantified the bidirectional association. People with diabetes have approximately three times the risk of developing periodontitis compared to people without diabetes. In the reverse direction, people with severe periodontitis have roughly twice the risk of developing type 2 diabetes compared to those with healthy gums.1
Epidemiologic studies confirm the prevalence pattern. A 2020 analysis found that people with diabetes have significantly higher rates of periodontal disease across all severity categories, and people with periodontitis show elevated rates of both diagnosed and undiagnosed diabetes.6 A 2018 meta-analysis examining the reverse direction found that among people clinically diagnosed with periodontitis, the prevalence of diabetes is substantially higher than in the general population.7
Three mechanisms drive the cycle
Chronic inflammation. Both conditions create systemic inflammatory states that reinforce each other. A 2022 meta-analysis found that people with both periodontitis and type 2 diabetes show significantly elevated levels of inflammatory mediators including TNF-alpha, IL-6, and C-reactive protein compared to those with either condition alone.5 Periodontal bacteria and their byproducts enter the bloodstream through inflamed gum tissue, triggering immune responses that worsen insulin resistance. At the same time, the inflammatory environment in diabetes impairs the body’s ability to fight periodontal infection.3
Advanced glycation end-products (AGEs). High blood sugar leads to the formation of AGEs, proteins or lipids that become glycated after exposure to sugars. A 2022 systematic review found that inflamed periodontal tissues in people with diabetes accumulate AGEs, which promote oxidative stress, impair tissue repair, and amplify the inflammatory response in gum tissue.4 AGE accumulation in periodontal tissue contributes to faster breakdown of the structures that support teeth.
Epigenetic signaling through microRNAs. Recent research has identified specific microRNAs (small RNA molecules that regulate gene expression) involved in both conditions. A 2024 systematic review mapped the miRNA profiles shared by type 2 diabetes and periodontitis, showing how these molecules create feedback loops that perpetuate inflammation and tissue damage in both metabolic and periodontal systems.2
If you have diabetes, your risk of gum disease is triple that of someone without diabetes. If you have severe gum disease and no diabetes diagnosis, your risk of developing type 2 diabetes is roughly doubled. Screening for one condition should prompt evaluation for the other.
Diabetic gum disease symptoms: what’s different
The symptoms of periodontal disease in people with diabetes often follow a more aggressive pattern than in people without diabetes. A 2017 systematic review of oral manifestations of diabetes identified several features specific to the diabetic population.19
Faster progression. Gum disease advances more rapidly in people with poorly controlled diabetes. The combination of impaired immune function and elevated inflammatory mediators accelerates the destruction of periodontal ligament and alveolar bone that anchor teeth.
Impaired healing. Wounds in the mouth heal more slowly in people with diabetes. After dental procedures, including routine cleanings or more invasive treatments like extractions, tissue repair takes longer and carries higher infection risk.
Abscess formation. People with diabetes are more prone to developing periodontal abscesses, pockets of pus that form when infection becomes localized. These abscesses can occur even with relatively mild periodontal disease.
Severe cases at younger ages. Periodontitis typically develops in middle age. In people with poorly controlled type 1 or type 2 diabetes, severe periodontal disease can appear in the third or fourth decade of life.
Silent progression. Early diabetic gum disease may not cause obvious pain. By the time symptoms like loose teeth or visible gum recession appear, significant bone loss may have already occurred.
The standard warning signs still apply: bleeding gums when brushing or flossing, persistent bad breath, gum recession, tooth mobility, and changes in bite alignment. People with diabetes should watch for these signs and report them promptly, because the window for preventing irreversible damage is shorter.
Which periodontal treatments work best for people with diabetes
Standard non-surgical periodontal therapy (scaling and root planing) works in people with diabetes, but several recent meta-analyses have compared different treatment protocols to identify which approaches optimize both periodontal and glycemic outcomes.
Scaling and root planing (the baseline treatment)
All the trials showing A1c reduction used scaling and root planing as the foundational intervention. This procedure involves cleaning below the gumline to remove plaque and tartar from tooth roots and smoothing root surfaces to discourage bacterial reattachment.89
A 2025 systematic review compared different protocols of non-surgical therapy (single-session full-mouth treatment versus quadrant-by-quadrant treatment over multiple visits). The review found no significant difference in glycemic outcomes between the two approaches, though full-mouth disinfection in a single session may reduce the time window during which bacteria can recolonize treated sites.15
Adjunctive antimicrobials (modest additional benefit)
Several trials have tested whether adding systemic or local antimicrobials to scaling and root planing improves outcomes beyond mechanical treatment alone.
A 2024 RCT tested adding amoxicillin and metronidazole (systemic antibiotics) to scaling and root planing in 60 people with type 2 diabetes and periodontitis. The adjunctive antibiotic group showed slightly better periodontal pocket reduction and attachment gain, but the difference in A1c reduction was not statistically significant compared to scaling and root planing alone.11
A 2025 network meta-analysis specifically examined local antimicrobials (antibiotics placed directly into periodontal pockets). The analysis found that adjunctive local antimicrobials improved pocket depth reduction by a small but measurable amount compared to scaling and root planing alone, but the added benefit for glycemic control was inconsistent across studies.18
The evidence suggests antimicrobials may help in cases of aggressive or refractory periodontitis, but they are not routinely necessary for most people with diabetes.
Laser-assisted therapy (no clear advantage)
A 2025 meta-analysis compared laser-assisted periodontal therapy to conventional scaling and root planing in people with diabetes. Laser treatment (typically erbium or diode lasers used to remove infected tissue and reduce bacteria) showed similar periodontal outcomes to conventional treatment but did not produce superior A1c reduction.17 Laser therapy is more expensive and not widely available. The current evidence does not support choosing laser treatment over standard mechanical debridement based on glycemic outcomes alone.
Photodynamic therapy (limited evidence, prediabetic benefit)
Photodynamic therapy uses a light-activated chemical to kill bacteria in periodontal pockets. A 2023 RCT in people with type 2 diabetes found that adding photodynamic therapy to scaling and root planing improved periodontal outcomes but did not significantly improve A1c compared to scaling and root planing alone.12
A separate 2023 trial in prediabetic patients (fasting glucose 100 to 125 mg/dL) found that photodynamic therapy as an adjunct to standard treatment helped stabilize fasting glucose levels and prevented progression toward diabetes over a six-month follow-up.13 This suggests a potential preventive role in the prediabetic population, though more research is needed.
Network meta-analysis verdict
A 2025 Bayesian network meta-analysis synthesized evidence from multiple treatment comparisons. The analysis found that intensive periodontal therapy (scaling and root planing plus ongoing maintenance visits) produced the best combined periodontal and glycemic outcomes. Adding adjuncts like antimicrobials or photodynamic therapy provided marginal additional benefit in specific cases but did not outperform well-executed mechanical treatment with regular follow-up.16
Standard scaling and root planing, combined with regular maintenance cleanings every three to four months, is the evidence-based foundation. Adjunctive treatments may help in specific situations (aggressive disease, poor response to initial treatment), but they do not replace thorough mechanical debridement and ongoing home care.
Other oral complications from diabetes
Periodontal disease is the most common oral complication of diabetes, but it is not the only one. A 2017 systematic review cataloged the full range of oral manifestations associated with diabetes.19
Xerostomia (dry mouth). Reduced salivary flow is common in people with diabetes, particularly those with poorly controlled blood sugar. Saliva contains antimicrobial proteins and helps buffer acids produced by oral bacteria. Reduced saliva increases the risk of cavities, fungal infections, and difficulty swallowing.
Oral candidiasis (thrush). Fungal infections, particularly with Candida albicans, occur more frequently in people with diabetes. High glucose levels in saliva create a favorable environment for fungal overgrowth. Oral thrush presents as white patches on the tongue, inner cheeks, or palate, and can cause burning or altered taste.
Burning mouth syndrome. Some people with diabetes experience a persistent burning sensation in the mouth without visible lesions. The cause is not fully understood but may involve neuropathy (nerve damage) affecting oral tissues.
Delayed wound healing. Any oral surgery, tooth extraction, or even minor trauma to the gums heals more slowly in people with diabetes. This increases the risk of infection and post-procedure complications.
Taste alterations. Changes in taste perception are reported by some people with diabetes, possibly related to neuropathy affecting taste buds or changes in saliva composition.
Lichen planus. This chronic inflammatory condition affecting mucous membranes appears at higher rates in people with diabetes. It presents as white, lacy patches or painful ulcers inside the mouth.
These complications are more common and more severe in people with poorly controlled diabetes. Improving glycemic control reduces the incidence and severity of most oral manifestations.
Prevention requires both blood sugar control and oral hygiene
Preventing the diabetes and gum disease cycle requires addressing both conditions simultaneously. Neither glycemic control alone nor oral hygiene alone is sufficient.
Glycemic control reduces periodontal risk. Maintaining A1c below 7% significantly reduces the risk of developing or worsening periodontal disease. The closer blood sugar stays to normal ranges, the lower the inflammatory burden and the better the body’s immune response to oral bacteria.1
Home oral hygiene is non-negotiable. Brushing twice daily with fluoride toothpaste, flossing or using interdental cleaners once daily, and limiting sugar intake all reduce plaque accumulation and gingival inflammation. People with diabetes should not assume that good blood sugar control alone will protect their gums.
Professional cleanings every three to four months. Standard dental care recommends cleanings every six months. People with diabetes, especially those with a history of periodontal disease, benefit from more frequent cleanings (every three to four months) to keep bacterial levels low and catch early signs of inflammation.1020
Early intervention matters. The earlier periodontal disease is detected and treated, the less irreversible damage occurs. Gingivitis (inflammation of the gums without bone loss) is fully reversible with treatment. Periodontitis (inflammation with bone loss) can be arrested but not reversed. Waiting until teeth become loose or painful means significant bone loss has already occurred.
Smoking cessation is critical. Smoking is the single largest modifiable risk factor for periodontal disease and also worsens insulin resistance. People with diabetes who smoke face compounded risk for both periodontal disease and diabetes complications.
Talk to your dentist about coordinating with your diabetes team
The evidence supporting the bidirectional relationship between diabetes and gum disease has led professional organizations to recommend coordinated care between dental and diabetes providers.
A 2021 umbrella review from the Canadian Dental Hygienists Association summarized the clinical implications. The review recommended that dental professionals screen for diabetes risk in patients with periodontal disease (using questionnaires or referrals for blood glucose testing) and that diabetes care providers ask about oral health and refer patients for dental evaluation.20
What coordinated care looks like in practice
Dentists should know your A1c. Bring a copy of your most recent lab results to dental appointments. Your dentist can use this information to assess periodontal disease risk and adjust the treatment plan accordingly.
Diabetes providers should ask about gum health. At routine diabetes visits, your doctor or diabetes educator should ask whether you have bleeding gums, loose teeth, or bad breath, and whether you are seeing a dentist regularly. Periodontal disease may signal the need for intensified diabetes management.
Shared treatment goals. Both your dental and diabetes care teams should understand that treating gum disease is not just about saving teeth. It is part of diabetes management. Similarly, improving glycemic control is not just about preventing kidney disease or blindness. It protects your oral health.
Communication between providers. In some integrated care systems, dental and medical records are linked, allowing providers to see each other’s notes. If your providers do not share a system, you can facilitate communication by asking your dentist to send a summary to your diabetes doctor (and vice versa) when significant findings or treatment plans are documented.
Insurance and coverage. Periodontal treatment in people with diabetes may qualify for medical insurance coverage in some cases, particularly when documented as part of diabetes management. Check with your insurance provider about coverage for scaling and root planing, and ask your dentist and diabetes doctor to provide documentation linking the treatment to diabetes care.
The bidirectional relationship between diabetes and gum disease means that managing one condition without addressing the other leaves you at higher risk for complications from both. Coordinated care treats the whole system, not isolated parts.
Sources
- Stöhr J, et al. Bidirectional association between periodontal disease and diabetes mellitus: a systematic review and meta-analysis of cohort studies. Sci Rep, 2021. PubMed
- Mata-Monterde M, et al. miRNAs as Epigenetic Biomarkers in the Study of the Bidirectional Relationship between Type 2 Diabetes Mellitus and Periodontitis: A Systematic Review. Int J Mol Sci, 2024. PubMed
- Hasan F, et al. Inflammatory Association between Periodontal Disease and Systemic Health. Inflammation, 2025. PubMed
- Chopra A, et al. Are Inflamed Periodontal Tissues Endogenous Source of Advanced Glycation End-Products (AGEs) in Individuals with and without Diabetes Mellitus? A Systematic Review. Biomolecules, 2022. PubMed
- Mattos MCO, et al. Expression of inflammatory mediators in periodontitis and T2D patients: a systematic review and meta-analysis. Braz Oral Res, 2022. PubMed
- Wu CZ, et al. Epidemiologic relationship between periodontitis and type 2 diabetes mellitus. BMC Oral Health, 2020. PubMed
- Ziukaite L, et al. Prevalence of diabetes mellitus in people clinically diagnosed with periodontitis: A systematic review and meta-analysis of epidemiologic studies. J Clin Periodontol, 2018. PubMed
- Simpson TC, et al. Treatment of periodontitis for glycaemic control in people with diabetes mellitus. Cochrane Database Syst Rev, 2022. PubMed
- Baeza M, et al. Effect of periodontal treatment in patients with periodontitis and diabetes: systematic review and meta-analysis. J Appl Oral Sci, 2020. PubMed
- D'Aiuto F, et al. Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial. Lancet Diabetes Endocrinol, 2018. PubMed
- Xu X, et al. Effects of amoxicillin and metronidazole as an adjunct to scaling and root planing on glycemic control in patients with periodontitis and type 2 diabetes: A short-term randomized controlled trial. J Periodontal Res, 2024. PubMed
- Brinar S, et al. The effect of antimicrobial photodynamic therapy on periodontal disease and glycemic control in patients with type 2 diabetes mellitus. Clin Oral Investig, 2023. PubMed
- Shetty B, et al. Effect of non-surgical periodontal therapy with adjunct photodynamic therapy on periodontal and glycemic statuses in prediabetic patients with periodontal disease. Photodiagnosis Photodyn Ther, 2023. PubMed
- Mizuno H, et al. The effects of non-surgical periodontal treatment on glycemic control, oxidative stress balance and quality of life in patients with type 2 diabetes: A randomized clinical trial. PLoS One, 2017. PubMed
- Corbella S, et al. Efficacy of different protocols of non-surgical periodontal therapy in patients with type 2 diabetes: A systematic review and meta-analysis. J Periodontal Res, 2025. PubMed
- Xie X, et al. Efficacy of nonsurgical periodontal treatment on patients with periodontitis and type 2 diabetes mellitus: a systematic review and Bayesian network meta-analysis. Acta Odontol Scand, 2025. PubMed
- Hegde R, et al. Efficacy of Laser Therapy versus Conventional Periodontal Treatment in Diabetic Patients with Periodontitis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Indian J Dent Res, 2025. PubMed
- de Oliveira DMSL, et al. Efficacy of Adjunctive Local Antimicrobials to Non-Surgical Periodontal Therapy in Pocket Reduction and Glycemic Control of Patients with Type 2 Diabetes: A Network Meta-Analysis. Curr Diabetes Rev, 2025. PubMed
- Mauri-Obradors E, et al. Oral manifestations of Diabetes Mellitus. A systematic review. Med Oral Patol Oral Cir Bucal, 2017. PubMed
- Lavigne SE, Forrest JL. An umbrella review of systematic reviews examining the relationship between type 2 diabetes and periodontitis: Position paper from the Canadian Dental Hygienists Association. Can J Dent Hyg, 2021. PubMed